Lumsden Alan B, Davies Mark G, Peden Eric K
Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin Street, Suite 1401, Houston, TX 77030, USA.
J Endovasc Ther. 2009 Apr;16(2 Suppl 2):II31-62. doi: 10.1583/08-2657.1.
Critical limb ischemia (CLI) is the term used to designate the condition in which peripheral artery disease has resulted in resting leg or foot pain or in a breakdown of the skin of the leg or foot, causing ulcers or tissue loss. If not revascularized, CLI patients are at risk for limb loss and for potentially fatal complications from the progression of gangrene and the development of sepsis. The management of CLI requires a multidisciplinary team of experts in different areas of vascular disease, from atherosclerotic risk factor management to imaging, from intervention to wound care and physical therapy. In the past decade, the most significant change in the treatment of CLI has been the increasing tendency to shift from bypass surgery to less invasive endovascular procedures as first-choice revascularization techniques, with bypass surgery then reserved as backup if appropriate. The goals of intervention for CLI include the restoration of pulsatile, inline flow to the foot to assist wound healing, the relief of rest pain, the avoidance of major amputation, preservation of mobility, and improvement of patient function and quality of life. The evaluating physician should be fully aware of all revascularization options in order to select the most appropriate intervention or combination of interventions, while taking into consideration the goals of therapy, risk-benefit ratios, patient comorbidities, and life expectancy. We discuss the incidence, risk factors, and prognosis of CLI and the clinical presentation, diagnosis, available imaging modalities, and medical management (including pain and ulcer care, pharmaceutical options, and molecular therapies targeting angiogenesis). The endovascular approaches that we review include percutaneous transluminal angioplasty (with or without adjunctive stenting); subintimal angioplasty; primary femoropopliteal and infrapopliteal deployment of bare nitinol, covered, drug-eluting, or bioabsorbable stents; cryoplasty; excimer laser-assisted angioplasty; excisional atherectomy; and cutting balloon angioplasty.
严重肢体缺血(CLI)是用于描述外周动脉疾病导致静息时腿部或足部疼痛,或腿部或足部皮肤破损,引起溃疡或组织缺失的病症。如果不进行血管再通,CLI患者面临肢体丧失的风险,以及因坏疽进展和脓毒症发展而引发潜在致命并发症的风险。CLI的管理需要一个多学科专家团队,涵盖血管疾病不同领域,从动脉粥样硬化危险因素管理到影像学,从介入治疗到伤口护理和物理治疗。在过去十年中,CLI治疗中最显著的变化是越来越倾向于从旁路手术转向侵入性较小的血管内手术作为首选的血管再通技术,若合适,旁路手术则留作备用。CLI干预的目标包括恢复足部的搏动性、直线血流以促进伤口愈合、缓解静息痛、避免大截肢、保持活动能力以及改善患者功能和生活质量。评估医生应充分了解所有血管再通选项,以便选择最合适的干预措施或干预措施组合,同时考虑治疗目标、风险效益比、患者合并症和预期寿命。我们讨论了CLI的发病率、危险因素和预后以及临床表现、诊断、可用的影像学检查方法和药物治疗(包括疼痛和溃疡护理、药物选择以及针对血管生成的分子疗法)。我们回顾的血管内治疗方法包括经皮腔内血管成形术(有无辅助支架置入);内膜下血管成形术;裸镍钛诺、覆膜、药物洗脱或可生物吸收支架在股腘动脉和腘下动脉的初次置入;冷冻球囊血管成形术;准分子激光辅助血管成形术;切除性旋切术;以及切割球囊血管成形术。